Lake Norman Hematology Oncology Specialists-Mooresville — Mooresville, North Carolina

Lake Norman Hematology Oncology Specialists-Mooresville is a clinical research site located in Mooresville, North Carolina, United States 28117.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Lake Norman Hematology Oncology Specialists-Mooresville has participated in 22 clinical trials with 4 currently active.

Therapeutic areas: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, Gynecologic Oncology Group.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lake Norman Hematology Oncology Specialists-Mooresville?

Lake Norman Hematology Oncology Specialists-Mooresville has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lake Norman Hematology Oncology Specialists-Mooresville conducted?

Lake Norman Hematology Oncology Specialists-Mooresville has 22 clinical trials on record, with 4 currently active. Their work covers Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Is Lake Norman Hematology Oncology Specialists-Mooresville accredited by Crixeo Health?

Yes — Lake Norman Hematology Oncology Specialists-Mooresville holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lake Norman Hematology Oncology Specialists-Mooresville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.